SK
Samir Kaul
Venture CapitalActiveFounding Partner and Managing Director at Khosla Ventures
13
Investments
0
Exits
—
AUM
0.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Samir Kaul.
Investment Thesis & Strategy
Samir Kaul, as a Managing Director at Khosla Ventures, invests in various stages across biotech, climatetech/cleantech, enterprise, food & beverage, and health & hospital services, seeking innovative and impactful companies within these sectors.
Investment Activity
Deals per year over the last 14 years
2
20063
20071
20080
20090
20101
20110
20121
20132
20141
20150
20160
20170
20181
2019Portfolio Companies
Selected investments from their portfolio of 13 companies
I
IgGenix
Biotech · Series A, 2019
Y
Yes Health
Healthcare · Seed, 2015
E
Eligo Bioscience
Biotech · Series A, 2014
S
Siolta Therapeutics
Biotech · Seed, 2014
S
SLD Laser
Other · Seed, 2013
C
Clothia
E-commerce · Seed, 2011
S
Sakti3
Cleantech · Series A, 2008
D
Draths Corporation
Biotech · Seed, 2007
S
Segetis
Cleantech · Seed, 2007
V
Virdia
Cleantech · Series A, 2007
R
Range Fuels
Cleantech · Series A, 2006
C
Codon Devices
Biotech · Seed, 2006
Frequently Asked Questions
Samir Kaul focuses on Series B stage investments.
Related Investors
Threshold
Menlo Park, United States · 841 deals
Lightspeed Venture Partners
Menlo Park, United States · 839 deals
Andreessen Horowitz
Menlo Park, United States · 826 deals
Khosla Ventures
Menlo Park, United States · 769 deals
Greylock
Menlo Park, United States · 720 deals
GGV Capital
Menlo Park, United States · 625 deals